Meningococcal B disease can make people sick very quickly and is good at spreading from person to person. Doctors are trying to find out the fastest way to give the vaccine in case there are a lot of people getting sick all at once.
This research study will look at two groups of 17 to 25 year olds. This age group tends to be at higher risk of meningococcal disease because of close person-to-person contact in social settings and where they live (university campus, dorms etc). The study will be using the Meningococcal B vaccine Bexsero, which is currently licensed and available in Canada
This study is being conducted by Dr. Soren Gantt at the VEC at BC Children’s Hospital in Vancouver.
If you are interested in participating, please fill in this form: http://vec.med.ubc.ca/contact-us/participate-in-research/
